No Harm, No Foul With DAPT After 4 Years

ACC Conference Reporter

ESC 2015 | LONDON — Four years of dual antiplatelet therapy did not significantly reduce net adverse cardiac events, but it also didn't increase bleeding risk nor did it drive higher mortality, researchers reported. Read More >>>

Keywords: ESC Congress


< Back to Listings